BellRing Brands reported a 2% increase in net sales to $598.7 million for Q2 fiscal 2026 but saw a decline in operating profit to $66 million, impacted by an $11 million inventory-related charge and higher costs from inflation and freight. Despite volume growth in its Premier Protein brand, margins were pressured by promotional activity and unfavorable sales mix. The company updated its full-year 2026 outlook with net sales expected between $2.325 billion and $2.365 billion and adjusted EBITDA between $315 million and $335 million, reflecting ongoing market challenges and continued investment in advertising. BellRing is also progressing with its CEO transition and continues share repurchases.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
Holtec Nuclear Corporation has filed a registration statement with the U.S. SEC for a proposed initial public offering (IPO) of its Class A common stock, planning to list on Nasdaq under the symbol "HNUC." The offering details, including share count ...
DeFi platform Aave introduced Stable Vaults, enabling fintechs and payment providers to offer fixed-rate stablecoin yields, enhancing its ecosystem. This launch, alongside the Aave V4 upgrade, increased token trading volume by 14.5% and price by near...
Morgan Stanley has filed to launch Ethereum and Solana ETFs with a competitive 0.14% management fee, aiming to capture market share as crypto ETFs become more commoditized. These ETFs will offer direct token exposure, staking rewards, and institution...
